Here, the TCGA database analysis showed that GLUT1, HK2, and other key glycolytic enzymes were highly expressed in and negatively correlated with the survival of HCC patients, suggesting they might be used as a new generation of tumour markers. This evidence concerns the gene HK2 and neoplasm.